Provided by Tiger Fintech (Singapore) Pte. Ltd.

Evelo Biosciences

0.0005
+0.0000
Volume:187.00
Turnover:0.09
Market Cap:9.49K
PE:0.00
High:0.0005
Open:0.0005
Low:0.0005
Close:0.0005
Loading ...

Company Profile

Company Name:
Evelo Biosciences
Exchange:
EXPERT
Establishment Date:
2014
Employees:
66
Office Location:
620 Memorial Drive,5th Floor,Cambridge,Massachusetts,United States
Zip Code:
02139
Fax:
- -
Introduction:
Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella parvula, which is in Phase 1b clinical trial; EDP2939, an investigational oral biologic for the potential treatment of inflammatory diseases; and EDP1908, a product candidate for oncology. Evelo Biosciences, Inc. was incorporated in 2014 and is headquartered in Cambridge, Massachusetts.